- Technology and Data
- Front End Sales and Marketing
- Allergy
- HIV
- Women's Health
- Migraine
- Compounding
- Continuous Glucose Monitoring
- Mental Health Awareness
- Veterinary Pharmacy
- CBD
- Infectious Disease
- Eye Health
- Digestive Health
- Biosimilars
- Influenza
- Shingles
- COPD Management
- Pediatrics
- Generics
- Pain Management
- COVID-19
- Immunization
- Oncology
- Anticoagulants
- Autoimmune Diseases
- Dermatology
- Diabetes
- Respiratory
- Heart Health
- Cardiovascular Clinical Consult
NACDS: Use of generics contributes to decline of Rx costs
The use of generic medications increased from 48.4% to 52.6% for third-party payers in 2006, according to data from Wolters Kluwer Health. Armed with these data, NACDS released the following statement: "This significant increase in generic drug use helped keep spending growth down, although overall prescriptions dispensed picked up due to the implementation of Medicare Part D. The cost of prescription medications as a contributor to overall healthcare costs has declined in recent years." The association also pointed to data from CMS, which showed that health expenditures rose 6.9% from 2004 to 2005, while prescription expenditures rose only 5.8%. "Community pharmacists play a vital role in helping to control healthcare expenditures by suggesting generic alternatives to brand-name drugs when appropriate and providing patients with important information regarding effective utilization of medication," said Robert Hannan, NACDS president/CEO. NACDS anticipates that generic use will continue to increase.
To see more Hot off the Press news articles, click here.
To go to the Drug Topics homepage, click here.
Pharmacists Play Unique Role in Advancing Health Equity for Patients With Chronic Disease
December 7th 2023A new study, outlined in a poster at ASHP Midyear 2023, identified 3 key themes associated with the ways in which pharmacists are positioned to advance health equity for patients with chronic diseases.
